E2F6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.513000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.060000E-01
Normal-vs-Stage2
8.373000E-01
Normal-vs-Stage3
1.189780E-01
Normal-vs-Stage4
1.533830E-01
Stage1-vs-Stage2
3.936000E-01
Stage1-vs-Stage3
6.427900E-02
Stage1-vs-Stage4
4.567000E-01
Stage2-vs-Stage3
3.991600E-02
Stage2-vs-Stage4
7.699800E-02
Stage3-vs-Stage4
2.256300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.259400E-01
Normal-vs-AfricanAmerican
1.921980E-01
Normal-vs-Asian
5.886400E-01
Caucasian-vs-AfricanAmerican
3.353400E-01
Caucasian-vs-Asian
1.347450E-01
AfricanAmerican-vs-Asian
3.759900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.288200E-01
Normal-vs-Female
6.316400E-01
Male-vs-Female
4.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.773170E-01
Normal-vs-Age(41-60Yrs)
3.451000E-01
Normal-vs-Age(61-80Yrs)
9.765800E-01
Normal-vs-Age(81-100Yrs)
7.060800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.068400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.040200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.430460E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.742540E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.219900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.454400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.637400E-01
Normal-vs-Daily Drinker
8.756600E-01
Normal-vs-Weekly Drinker
9.892000E-01
Normal-vs-Occasional Drinker
3.319800E-01
Normal-vs-Social Drinker
3.719600E-01
Non Drinker-vs-Daily Drinker
1.640570E-01
Non Drinker-vs-Weekly Drinker
2.999800E-01
Non Drinker-vs-Occasional Drinker
2.215700E-03
Non Drinker-vs-Social Drinker
7.697000E-03
Daily Drinker-vs-Weekly Drinker
7.850000E-01
Daily Drinker-vs-Occasional Drinker
1.728960E-01
Daily Drinker-vs-Social Drinker
3.277000E-01
Weekly Drinker-vs-Occasional Drinker
9.981900E-02
Weekly Drinker-vs-Social Drinker
1.783240E-01
Occasional Drinker-vs-Social Drinker
6.773400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.006380E-01
Normal-vs-Grade 2
2.683600E-02
Normal-vs-Grade 3
1.640230E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.448200E-01
Grade 1-vs-Grade 3
9.685000E-01
Grade 1-vs-Grade 4
1.006380E-01
Grade 2-vs-Grade 3
5.702800E-01
Grade 2-vs-Grade 4
2.683600E-02
Grade 3-vs-Grade 4
1.640230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.071400E-01
Normal-vs-NonDiabetic
7.089000E-01
Diabetic-vs-NonDiabetic
5.570000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.862600E-01
Normal-vs-NoPancreatitis
8.484200E-01
Pancreatitis-vs-NoPancreatitis
7.881200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.432600E-01
Normal-vs-N1
7.996200E-01
N0-vs-N1
7.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.419800E-01
Normal-vs-TP53-NonMutant
1.861610E-01
TP53-Mutant-vs-TP53-NonMutant
3.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
